The Insights and Perspectives of Nitric Oxide-mediated Biofilm Eradication

Curr Top Med Chem. 2021;21(24):2213-2229. doi: 10.2174/1568026621666210701113043.

Abstract

Biofilms are among the most important causes of nosocomial and recurrent infections as biofilms confer antibiotic resistance to pathogenic bacteria and protect them from the host's immune system. Thus, it is imperative to investigate effective therapeutic agents to counteract biofilms. As an important signaling molecule, Nitric Oxide (NO) plays a crucial role in various biological and pathological processes. NO could disperse biofilm and restore the drug sensitivity by reducing intracellular cyclic-diguanosine monophosphate (c-di-GMP) levels. This review highlights recent advances on antibacterial and antibiofilm effects of NO when NO was co-administered with other antimicrobial agents. A significant improvement in drug permeability and biofilm cell targeting and reduced cytotoxicity could be attained with this strategy. In this review, we briefly lay out challenges and propose future directions in this appealing avenue of research on NO-based therapy for biofilm eradication.

Keywords: Antibacterial therapy; Antibiotic resistance; Biofilm eradication; Bis-(3′-5′)-cyclic-diguanosine monophosphate (c-di- GMP); Nitric oxide (NO); Pathogenic infection..

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Biofilms / drug effects*
  • Humans
  • Nitric Oxide / pharmacology*
  • Nitric Oxide / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Nitric Oxide